Page Banner

United States Department of Agriculture

Agricultural Research Service

Research Project: EVALUATION OF RECOMBINANT HERPRESVIRUS-OF-TURKEYS VACCINE AGAINST AVIAN INFLUENZA H5N1

Location: Exotic and Emerging Avian Viral Diseases Research Unit

Project Number: 6612-32000-062-01
Project Type: Trust

Start Date: Dec 01, 2008
End Date: Nov 30, 2013

Objective:
1. Determine seroconversion against avian influenza following in ovo and day-of-age vaccination of specific pathogen free (SPF) and commercial chickens with recombinant herpesvirus of turkeys (HVT)-vectored avian influenza (AI) vaccine. 2 Determine vaccine efficacy following vaccination with recombinant HVT/AI vaccine against highly pathogenic avian influenza (HPAI) H5N1 challenge.

Approach:
Avian influenza (AI) hemagglutinin (HA) gene from current H5 field viruses was cloned into a herpesvirus of turkeys (HVT) vaccine. The HVT-AI vaccines, expressing HA protein, will be injected in SPF and commercial poultry to determine immune response and protection against HPAI challenge. Efficacy will be determined using high pathogenicity AI chicken models with measurement of protection being prevention of morbidity and mortality, reduction in number of infected birds and a decrease in the AI-shed from respiratory and alimentary tracts.

Last Modified: 9/21/2014
Footer Content Back to Top of Page